Minerva ginecologica最新文献

{"title":"Does hysterosalpingo-foam sonography have any therapeutic effect? A systematic review.","authors":"Maria G Piccioni,&nbsp;Sara Tabacco,&nbsp;Lucia Merlino,&nbsp;Valentina Del Negro,&nbsp;Allegra Mazzeo,&nbsp;Alessandra Logoteta,&nbsp;Federica Del Prete,&nbsp;Lucia Riganelli,&nbsp;Andrea Giannini,&nbsp;Marco Monti","doi":"10.23736/S0026-4784.20.04514-1","DOIUrl":"https://doi.org/10.23736/S0026-4784.20.04514-1","url":null,"abstract":"<p><strong>Introduction: </strong>Tubal patency is one of the mandatory and necessary conditions to be granted in order to guarantee a good pregnancy rate. Numerous studies have been conducted to compare the various testing techniques for tubal evaluation in order to optimize the diagnostic-therapeutic process. Aim of this review is to clarify if hysterosalpingo-foam sonography could be considered as a useful tool not only in the diagnostic procedure, but also in treatment of infertility.</p><p><strong>Evidence acquisition: </strong>We performed a comprehensive search of relevant studies from January 2010 to December 2019 to ensure all possible studies were captured. A systematic search of PubMed databases was conducted.</p><p><strong>Evidence synthesis: </strong>Over the years, increasingly less invasive approaches have been used to test tubal patency. For many years Laparoscopic with chromopertubation (DLS) has been considered the reference standard, then less invasive procedures have been introduced, such as hysterosalpingography (HSG). Sonohysterosalpingography (HyCoSy) represents a non-invasive procedure with accuracy comparable to HSG. Several studies have been made on different contrast agents that could be used on this procedure and recent studies considered hysterosalpingo-foam sonography (HyFoSy) procedure as a new technique used for the study of tubal function performed on unfertile women. Nowadays, HyFoSy is largely used in the study of tubal patency, but it is not completely clear the role of this technique as treatment of imperviousness of Fallopian tubes, leading to an increase in pregnancy rate after its use.</p><p><strong>Conclusions: </strong>As described in the literature for other procedures, similarly with HyFoSy, the tubal flushing improves the chance of an embryo implanting and establishing a spontaneous pregnancy. More prospective studies should be taken to better analyze the singular maternal risk fators, hoping to offer more complete indications to recommend HyFoSy.</p>","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"72 1","pages":"55-58"},"PeriodicalIF":1.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37720676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outpatient vaginal surgery for pelvic organ prolapse: a prospective feasibility study.","authors":"Géry Lamblin,&nbsp;Christophe Courtieu,&nbsp;Chloé Bensouda-Miguet,&nbsp;Laure Panel,&nbsp;Stéphanie Moret,&nbsp;Philippe Chabert,&nbsp;Gautier Chene,&nbsp;Erdogan Nohuz","doi":"10.23736/S0026-4784.20.04510-4","DOIUrl":"https://doi.org/10.23736/S0026-4784.20.04510-4","url":null,"abstract":"<p><strong>Background: </strong>In the light of recent progress in pelvic organ prolapse surgery, the modalities of hospital admission need reconsidering. This work aims to assess success rate of outpatient (ambulatory) vaginal mesh surgery for genital prolapse.</p><p><strong>Methods: </strong>A prospective observational study was conducted between January 2015 and July 2017, including all patients presenting with POP-Q stage ≥3 anterior and/or apical prolapse.</p><p><strong>Results: </strong>Sixty-nine of the 89 eligible patients were treated on an ambulatory basis (group A); 20 required overnight admission (group B): i.e., ambulatory success rate, 77.5%. Mean operative time was 44.9±2.5 min in group A and 62±6.5 min in group B. Reasons for ineligibility for ambulatory management comprised organizational issues at home (10.5%) and excessive home-to-hospital distance (5.7%). The postoperative urinary retention rate was 4.5%. Rates for successful cystocele correction (POP-Q <2) at 2 months were similar in the two groups: 94.2% in group A and 94.4% in group B (P=ns). Mean satisfaction score was 8.6±0.3/10.</p><p><strong>Conclusions: </strong>Outpatient anterior vaginal mesh surgery for prolapse is safe and effective. The current medical-economic context favors ambulatory management. Patient selection, prior information and continuity of care seem primordial.</p>","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"72 1","pages":"19-24"},"PeriodicalIF":1.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37722246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Female patient preferences regarding physician gender: a national survey.","authors":"Tiffanie Y Tam,&nbsp;Austin M Hill,&nbsp;Abigail Shatkin-Margolis,&nbsp;Rachel N Pauls","doi":"10.23736/S0026-4784.20.04502-5","DOIUrl":"https://doi.org/10.23736/S0026-4784.20.04502-5","url":null,"abstract":"<p><strong>Background: </strong>The number of male medical students selecting Obstetrics and Gynecology (OBGYN) has declined in recent years. However, it is unclear whether patients prioritize a female provider. The aim of the study was to assess gender preferences amongst female patients regarding their OBGYN and other medical providers. A secondary aim was to evaluate qualities that are important to female patients regarding their OBGYN.</p><p><strong>Methods: </strong>This was a USA cross-sectional survey using an internet-based provider (SurveyMonkey®) in January 2019. A 19-item questionnaire was distributed to females aged 18-80. The survey queried demographics, gender preferences for medical providers and important qualities in selecting their OBGYN. A goal of 1000 responses was determined for the study.</p><p><strong>Results: </strong>One thousand and fifteen women completed the entire survey. Sixty-six percent of respondents (N.=667) preferred a female OBGYN, while 8% (N.=87) preferred male, 25% (N.=261) no preference. The majority (51%) voiced no gender preference regarding other providers (N.=521). When asked to rank the 3 most important qualities in selecting their OBGYN, experience (57%), knowledge (51%), reputation (35%) and personality (34%) were most frequently chosen amongst the top 3. Gender was listed among the 3 important qualities by only 8% (N.=88). Women who identified as single, <45 years of age, and nulliparous had a higher likelihood of preferring a female OBGYN (P<0.003).</p><p><strong>Conclusions: </strong>Majority of women reported a female preference when selecting an OBGYN. However, when compared to other qualities, it is deemed less important. Male medical students considering OBGYN should be reassured by this information.</p>","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"72 1","pages":"25-29"},"PeriodicalIF":1.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37722247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Myasthaenia gravis in pregnancy, delivery and newborn.","authors":"Maria G Piccioni,&nbsp;Sara Tabacco,&nbsp;Andrea Giannini,&nbsp;Marianna Deroma,&nbsp;Alessandra Logoteta,&nbsp;Marco Monti","doi":"10.23736/S0026-4784.20.04505-0","DOIUrl":"https://doi.org/10.23736/S0026-4784.20.04505-0","url":null,"abstract":"<p><strong>Introduction: </strong>Myasthaenia gravis (MG) is the most common disease of the neuromuscular junction; clinical presentation of the disease includes a variety of symptoms, the most frequent beign the only ocular muscles involvement, to the generalized myasthenic crisis with diaphragmatic impairment and respiratory insufficiency. It is most common in women between 20 ad 40 years.</p><p><strong>Evidence acquisition: </strong>We performed a comprehensive search of relevant studies from January1990 to Dicember 2019 to ensure all possible studies were captured. A systematic search of Pubmed databases was conducted.</p><p><strong>Evidence synthesis: </strong>Pregnancy has an unpredictable and variable effect on the clinical course of MG; however, a stable disease before is likely not to relapse during pregnancy. exacerbations can still occur more often during the first trimester and the post partum period. The transplacental passage of antibodies results in a neonatal transient disease, whereas the major concern is related to foetal malformations such as fetal arthrogryposis and polyhydramnios. The overall neonatal outcome described in literature is variable, perinatal mortality in women with MG is generally the same as non affected patients, although in one study the risk of premature rupture of the membranes was higher. Treatment of MG in pregnangncy includes pyridostigmine and corticosteroids, although the latter have been associated with higher risk of cleft palate, premature rupture of the membranes and preterm delivery. These drugs appear also to be safe in breastfeeding. In MG patients spontaneous vaginal delivery should be encouraged, for surgery could cause acute worsening of myasthenic symptoms; also an accurate anesthesiological evaluation must be performed prior to both general and local anesthesia due to increased risk of complications.</p><p><strong>Conclusions: </strong>Most of the myasthenic women could have uneventful pregnancy with good obstetrical outcomes, both for mother and neonate. However, a careful planning of pregnancy and multidisciplinary team approach, composed by neurologists, obstetricians, neonatologists and anesthesiologists, is required to manage these pregnancies.</p>","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"72 1","pages":"30-35"},"PeriodicalIF":1.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37722248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment algorithm for women with endometriosis in a certified Endometriosis Unit.","authors":"Sebastian Findeklee,&nbsp;Julia C Radosa,&nbsp;Amr Hamza,&nbsp;Bashar Haj Hamoud,&nbsp;Iulian Iordache,&nbsp;Panagiotis Sklavounos,&nbsp;Zoltan F Takacs,&nbsp;Erich F Solomayer,&nbsp;Marc Radosa","doi":"10.23736/S0026-4784.20.04490-1","DOIUrl":"https://doi.org/10.23736/S0026-4784.20.04490-1","url":null,"abstract":"<p><strong>Introduction: </strong>Endometriosis is a chronic hormone-dependent disease affecting approximately 25-30% of women in the third and fourth decade. Despite its frequency, it is often detected late. The aim of this overview article was to present a standardized treatment algorithm for an interdisciplinary endometriosis consultation considering conservative and surgical approaches.</p><p><strong>Evidence acquisition: </strong>Despite the frequency of endometriosis and a high number of publications dealing with the disease there is a lack of evidence in literature for standardized treatment algorithms allowing a rational diagnostic and therapeutic approach. In May 2019 we did a literature search in Medline. While finding 26702 publications under the term \"endometriosis\" there was only one publication for the search term \"endometriosis consultation treatment algorithm.\" After screening the abstracts 144 publications in English, French or German language had been assessed as relevant for the diagnosis and therapy of endometriosis (143 overview articles and one guideline).</p><p><strong>Evidence synthesis: </strong>Based on clinical evidence, we have developed a treatment algorithm for women with suspected endometriosis. The diagnosis includes a structured medical history with the identification of endometriosis-typical symptoms and a gynecological examination, if necessary additional examinations. The treatment algorithm is essentially divided into the phase of diagnosis and the phase of therapy as well as the prevention of recurrence or long-term treatment. A multi-professional team of visceral surgery, urology, nutritional medicine, physiotherapy and psychology can be consulted for support.</p><p><strong>Conclusions: </strong>The treatment of endometriosis should be multiprofessional, standardized and reproducible during specialized consultations at certified centers. So far, there are few publications on a standardized and clinically proven treatment algorithm for women with suspected endometriosis. The presented treatment algorithm could be helpful in the diagnosis and treatment of endometriosis patients, even at other centers.</p>","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"72 1","pages":"43-49"},"PeriodicalIF":1.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37720674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Uterus transplantation: transition from experimental to clinical procedure.","authors":"Mats Brännström","doi":"10.23736/S0026-4784.19.04482-4","DOIUrl":"https://doi.org/10.23736/S0026-4784.19.04482-4","url":null,"abstract":"<p><p>Uterus transplantation is a novel treatment to treat uterine factor infertility. This type of infertility is due to absence of an anatomical or functional uterus. This review covers important research findings in the field, and this research formed the base for introduction of uterus transplantation as an experimental clinical procedure. The basic animal-research investigated central facets such as surgery, immunosuppression, ischemia-reperfusion injury, rejection, and fertility. The first clinical uterus transplantation trial was started in 2013 and this was a live donor trial. The first live birth was reported in 2014 and this has been followed by a number of births from the initial trial in Sweden and in several other parts of the world. The uterus transplantations procedures and the live births that have been scientifically reported will be discussed in this review. Lastly, some aspects for an efficient transition from an experimental phase into a clinical phase of uterus transplantation will be discussed.</p>","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"71 6","pages":"460-466"},"PeriodicalIF":1.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37649301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of robotic surgery performed in patients with high BMI class: experience by a single surgeon.","authors":"Gianluca R Damiani,&nbsp;Mario Villa,&nbsp;Edoardo Di Naro,&nbsp;Mauro Signorelli,&nbsp;Silvia Corso,&nbsp;Giuseppe Trojano,&nbsp;Matteo Loverro,&nbsp;Teresa Capursi,&nbsp;Giuseppe Muzzupapa,&nbsp;Antonio Pellegrino","doi":"10.23736/S0026-4784.19.04440-X","DOIUrl":"https://doi.org/10.23736/S0026-4784.19.04440-X","url":null,"abstract":"<p><strong>Background: </strong>Advanced laparoscopic procedures have been shown to be safe in patients with high Body Mass Index (BMI), but conversion rates remain high. This analysis aimed to evaluate the feasibility and clinical outcomes in terms of long- and short-term complications, pain relief of robotic surgery in morbidly obese patients.</p><p><strong>Methods: </strong>Patients with BMI class I-II-III with endometrial cancer or hyperplasia were treated with robotic hysterectomy (RH). Patients' characteristics, operating room time (OT), type of surgery, length of hospital stay, and incidence of complications were recorded. Records were reviewed for demographic data, medical/surgical history and comorbidities, perioperative findings and outcomes, as well as long-term complications and recurrences. Regarding stage, according to 2009 FIGO, 26 of cases were IA, while eight and five of cases were, respectively, IB, II stage.</p><p><strong>Results: </strong>A total of 87 consecutive RH were analyzed. The more frequent comorbidity was hypertension. Twenty percent of the patients had multiple comorbidities (>2). The mean age was 63±10 years, with a mean BMI of 36±8.2 kg/m2. The more frequent BMI group treated was II class. The median OT was 114 minutes (range: 49-270). According to the Dindo Classification, there were no differences in major or minor complications between the 3 BMI classes. This series had a median follow-up of 60 months (range: 8-96) with an overall survival rate of 100%. The RRH+PLH was feasible and pathology confirmed the adequacy of the surgical specimen, with a median count of 20 nodes.</p><p><strong>Conclusions: </strong>Our data support the adoption of the surgical management of the morbidly obese patient. Although short term complication rates are higher with increasing obesity (II-III class), a majority of procedures can still be completed with minimally invasive approach.</p>","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"71 6","pages":"412-418"},"PeriodicalIF":1.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37649407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of non-gynecological symptoms before and after removal of the Essure® sterilization device: a 6-month follow-up study.","authors":"Philippe Merviel,&nbsp;Dorothee Kurtz,&nbsp;Caroline Lelievre,&nbsp;Anne Le Gourrierec,&nbsp;Edith Postec-Ollitrault,&nbsp;Pierre-François Dupré","doi":"10.23736/S0026-4784.19.04391-0","DOIUrl":"https://doi.org/10.23736/S0026-4784.19.04391-0","url":null,"abstract":"<p><strong>Background: </strong>Most of the clinical adverse events associated with the Essure® sterilization device have been attributed to incidents during and immediately after device placement (perforation, infection, expulsion). The aim of this study was to prospectively evaluate the prevalence and severity of non-gynecological clinical symptoms (e.g. memory disorders, muscle pain, and impaired vision) in patients before device placement and after device removal.</p><p><strong>Methods: </strong>Women who presented at least four non-gynecological clinical symptoms with the Essure® filled out a questionnaire before surgical removal of the device and then 1, 3 and 6 months afterwards. Patients with bleeding (metrorrhagia and menorrhagia) or tube perforation were excluded.</p><p><strong>Results: </strong>Fifty-two symptomatic women were included in the study and followed up for 6 months. The median (range) time interval between Essure® placement and the first clinical symptom was 13 months (1-60), and the median time interval between Essure® placement and removal was 38 months (12-72). The prevalence of clinical symptoms prior to device removal ranged from 26% (for urinary tract disorders) to 96% (for weakness). The mean±standard deviation intensity (on a 0-to-10 scale) of the symptoms before removal of the Essure® was 8.4±0.4; at 1 month, 3 months and 6 months post-removal, the values had fallen significantly to 4.2±0.6, 4±0.8, and 4.1±1, respectively (P<0.0001 for all the symptoms).</p><p><strong>Conclusions: </strong>The observed decrease in symptom frequency and severity following Essure® removal and the persistence of this effect at 6 months suggest that the device should be removed in all symptomatic women.</p>","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"71 6","pages":"404-411"},"PeriodicalIF":1.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37649406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of antenatal education for the prevention of excessive weight gain during pregnancy.","authors":"Roberta Amadori,&nbsp;Carmela Melluzza,&nbsp;Alessia Motta,&nbsp;Alberto De Pedrini,&nbsp;Daniela Surico","doi":"10.23736/S0026-4784.19.04449-6","DOIUrl":"https://doi.org/10.23736/S0026-4784.19.04449-6","url":null,"abstract":"<p><strong>Background: </strong>Excessive weight gain (EWG) during pregnancy is associated to adverse maternal-fetal outcomes. The aim of this study was to analyze the situation in a single high intensity care center in Eastern Piedmont, north of Italy.</p><p><strong>Methods: </strong>This is a cohort study including 715 patients classified into four classes corresponding to pregestational BMI values. Based on the WHO's weight gain for each class, women were subdivided into three groups: inadequate, adequate and excessive increase.</p><p><strong>Results: </strong>EWG was significant in overweight (43.9%) and obese women (37.3%). There was a significant correlation with gestational diabetes (P=0.046), hypertension (P=0.0001), preterm birth (P=0.047), intake of antihypertensive drugs (P=0.0001), maternal study degree (P=0.005), profession (P=0.015), civil status (P=0.003), parity (P=0.039) and paternal ethnicity (P=0.027). Participation at antenatal education for childbirth (AEC) had a positive impact leading to an appropriate weight gain (P=0.004).</p><p><strong>Conclusions: </strong>If adequately counselled, women understand the consequences of excessive weight gain during pregnancy, comply more to therapy and modify their lifestyle.</p>","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"71 6","pages":"427-433"},"PeriodicalIF":1.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37649408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevention of vaginal dryness in perimenopausal women. Supplementation with Lady Prelox®.","authors":"Maria R Cesarone,&nbsp;Gianni Belcaro,&nbsp;Claudia Scipione,&nbsp;Valeria Scipione,&nbsp;Mark Dugall,&nbsp;Shu Hu,&nbsp;Roberto Cotellese,&nbsp;Beatrice Feragalli,&nbsp;Andrea Ledda","doi":"10.23736/S0026-4784.19.04466-6","DOIUrl":"https://doi.org/10.23736/S0026-4784.19.04466-6","url":null,"abstract":"<p><strong>Background: </strong>The aim of this pilot registry study was to use a standardized supplement (Lady Prelox®, Horphag Research) - including Pycnogenol®, l-arginine, L-citrulline and rose hip extract - to improve signs and symptoms associated with vaginal dryness in pre and post-menopausal healthy women. A group of women used only a standard management (SM) and a second group added Lady Prelox®.</p><p><strong>Methods: </strong>Four groups of women were included in the study. 34 pre-menopausal and 38 post-menopausal women took Lady Prelox®, four tablets daily for 8 weeks and 33 pre-menopausal women and 35 post-menopausal women served as controls.</p><p><strong>Results: </strong>No safety problems were observed with the supplement that was well tolerated. The subgroups of controls and supplemented subjects were comparable in both the pre- and post-menopausal groups. Among pre-menopausal women, results of the female sexual function index (FSFI) were significantly improved with the supplement in comparison with the control subjects' group (P<0.05). The results of the FSFI questionnaire for post-menopausal women indicated a significant improvement at 8 weeks with Lady Prelox® (P<0.05) in comparison with controls. Preclinical items (vaginal dryness, pain/discomfort during intercourse, mucus, minimal infections, presence of candida and oxidative stress) were significantly improved (P<0.05) with Lady Prelox®) in comparison to minimal changes with the SM group. These measurements included all women.</p><p><strong>Conclusions: </strong>The effects of the supplementation with Lady Prelox® on vaginal dryness were significant. The supplement was well accepted and revealed no side effects or tolerability problems. Further studies are evaluating the effects of Lady Prelox® on other aspects of the menopausal transition that may alter the quality of life of most women in advanced age. A gentle approach with suitable dietary supplementation, represents a promising option for addressing common challenges that women experience in such conditions.</p>","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"71 6","pages":"434-441"},"PeriodicalIF":1.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37649300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}